Patent · US Active

Dosage forms containing fluticasone propionate for the treatment of inflammatory conditions of the esophagus

US9980975B2 · kind B2 · utility

0Cited by
2References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 22, 2015
Grant dateMay 29, 2018
Priority date
Expiry dateJan 22, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P1/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention describes novel and improved dosage forms containing fluticasone propionate for the treatment of conditions associated with inflammation of the esophagus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.